Over the past 12 months, 5 insiders at Sagimet Biosciences Inc. filed 8 open-market SEC Form 4 transactions on SGMT: 0 purchases worth $0 and 8 sales worth $1.1M. Insiders have been net sellers over this period. The most recent filing was on Jul 20, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 20, 26 | David HappelPresident & CEO, Director | SELL | 64.1K | $7.76 | $497K |
| Jul 20, 26 | George KembleDirector | SELL | 18.8K | $7.46 | $141K |
| Jul 20, 26 | Elizabeth RozekChief Legal & Admin. Officer | SELL | 10.5K | $7.76 | $82K |
| Feb 10, 26 | Thierry ChaucheChief Financial Officer | SELL | 1.3K | $5.36 | $7K |
| Feb 10, 26 | David HappelPresident & CEO | SELL | 12.1K | $5.36 | $65K |
| Feb 10, 26 | Eduardo Bruno MartinsChief Medical Officer | SELL | 3.6K | $5.36 | $20K |
| Feb 10, 26 | Elizabeth RozekChief Legal & Admin. Officer | SELL | 2.6K | $5.36 | $14K |
| Nov 20, 25 | George KembleExecutive Chairman | SELL | 37.7K | $7.69 | $290K |
| Jul 21, 25 | David HappelPresident & CEO | SELL | 65.5K | $9.13 | $598K |
| Jul 21, 25 | Eduardo Bruno MartinsChief Medical Officer | SELL | 8.3K | $9.13 | $76K |
| Jul 21, 25 | Elizabeth RozekGeneral Counsel and CCO | SELL | 10.8K | $9.13 | $98K |
| Jul 23, 24 | George KembleExecutive Chairman | SELL | 23.6K | $3.17 | $75K |
| Jul 19, 24 | George KembleExecutive Chairman | SELL | 14.1K | $3.10 | $44K |
| Jul 19, 24 | Eduardo Bruno MartinsChief Medical Officer | SELL | 8.4K | $3.10 | $26K |
| Jul 19, 24 | Elizabeth RozekGeneral Counsel and CCO | SELL | 10.9K | $3.10 | $34K |
| Mar 26, 24 | David HappelPresident & CEO | BUY | 12.1K | $5.27 | $64K |
| Dec 7, 23 | David HappelPresident & CEO | BUY | 1.6K | $4.10 | $7K |
| Nov 16, 23 | David HappelPresident & CEO | BUY | 590 | $2.35 | $1K |
| Jul 18, 23 | Patrick J KerinsTenPercentOwner | BUY | 30.0K | $16.00 | $480K |
| Jul 18, 23 | Patrick J KerinsTenPercentOwner | SELL | 662 | $16.00 | $11K |
| Jul 18, 23 | Beth C SeidenbergDirector | BUY | 46.9K | $16.00 | $750K |
Over the past 12 months, insiders at Sagimet Biosciences Inc. filed 0 open-market purchases worth $0 and 8 sales worth $1.1M on SGMT, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 20, 26.
The largest recent open-market SGMT insider purchase in our data was $750K by Beth C Seidenberg, Director, filed on Jul 18, 23.
5 different insiders at Sagimet Biosciences Inc. filed open-market SEC Form 4 transactions on SGMT over the last 12 months.
InsiderTape plots every SGMT insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Sagimet Biosciences Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →